BeOne Medicines (ONC) Inventory (2017 - 2026)

BeOne Medicines (ONC) has 10 years of Inventory data on file, last reported at $681.6 million in Q1 2026.

• On a quarterly basis, Inventory rose 37.79% year-over-year to $681.6 million in Q1 2026; TTM through Mar 2026 was $681.6 million, a 37.79% increase from a year earlier, with the FY2025 full-year figure at $608.2 million, up 22.88% from the prior year.
• Inventory for Q1 2026 stood at $681.6 million, up from $608.2 million in the prior quarter.
• Over the last five years, Inventory for ONC reached as high as $681.6 million in Q1 2026 and fell as low as $245.6 million in Q1 2022.
• Historically, Inventory has averaged $415.8 million across 5 years, with a median of $431.7 million in 2024.
• Across the five-year window, Inventory soared 236.6% in 2022 and grew 8.94% in 2023, its largest moves.
• Year by year, Inventory stood at $282.3 million in 2022, then soared by 47.38% to $416.1 million in 2023, then increased by 18.95% to $495.0 million in 2024, then increased by 22.88% to $608.2 million in 2025, then increased by 12.06% to $681.6 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $681.6 million in Q1 2026, $608.2 million in Q4 2025, and $531.7 million in Q3 2025.